Literature DB >> 12849705

Hypoglycaemia downregulates endotoxin-induced production of tumour necrosis factor-alpha, but does not affect IL-1beta, IL-6, or IL-10.

B E de Galan1, M G Netea, P Smits, J W M van der Meer.   

Abstract

The aim of the present study was to investigate the effect of hypoglycaemia on the production capacity of the proinflammatory cytokines tumour necrosis factor-alpha (TNFalpha) and interleukin-1beta (IL-1beta) in subjects with and without diabetes. Hyperinsulinaemic (360 pmolm(-2) x min(-1)) stepped hypoglycaemic (5.0-3.5-2.5 mmoll(-1)) glucose clamps were performed in eight diabetic patients and in six non-diabetic subjects, and hyperinsulinaemic normoglycaemia (5.0 mmoll(-1)) control experiments were performed in four non-diabetic subjects. Circulating levels of cytokines and endotoxin-induced production of TNFalpha, IL-1beta, IL-6, and IL-10 were assessed. The effects of insulin and adrenaline were measured in separate in vitro experiments. In non-diabetic subjects, hypoglycaemia downregulated the production capacity of TNFalpha in a concentration-dependent fashion (P=0.007), but not of IL-1beta, IL-6, or IL-10. Compared to controls, the production capacity of TNFalpha in diabetic patients was already suppressed at normoglycaemia (P=0.02) and only fell in response to hypoglycaemic nadir (P=0.04). The downregulation of TNFalpha could not be explained by increased insulin or adrenaline levels. We conclude that hypoglycaemia specifically downregulates TNFalpha production capacity. Diabetic patients already have a suppressed TNFalpha production capacity at non-hypoglycaemic levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12849705     DOI: 10.1016/s1043-4666(03)00113-3

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  5 in total

1.  Short-term but not long-term hypoglycaemia enhances plasma levels and hepatic expression of HSP72 in insulin-treated rats: an effect associated with increased IL-6 levels but not with IL-10 or TNF-α.

Authors:  Mirna Stela Ludwig; Vânia Cibele Minguetti-Câmara; Thiago Gomes Heck; Sofia Pizzato Scomazzon; Patrícia Renck Nunes; Roberto Barbosa Bazotte; Paulo Ivo Homem de Bittencourt
Journal:  Mol Cell Biochem       Date:  2014-08-06       Impact factor: 3.396

2.  Broad Infiltration of Macrophages Leads to a Proinflammatory State in Streptozotocin-Induced Hyperglycemic Mice.

Authors:  Shuo Niu; Zhen Bian; Alexandra Tremblay; Youqun Luo; Koby Kidder; Ahmed Mansour; Ke Zen; Yuan Liu
Journal:  J Immunol       Date:  2016-09-12       Impact factor: 5.422

3.  Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630].

Authors:  Cornelia W Hoedemaekers; Peter Pickkers; Mihai G Netea; Marcel van Deuren; Johannes G Van der Hoeven
Journal:  Crit Care       Date:  2005-11-16       Impact factor: 9.097

Review 4.  Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.

Authors:  Clementine E M Verhulst; Therese W Fabricius; Steven Teerenstra; Peter L Kristensen; Cees J Tack; Rory J McCrimmon; Simon Heller; Mark L Evans; Stephanie A Amiel; Ulrik Pedersen-Bjergaard; Bastiaan E de Galan
Journal:  Diabetologia       Date:  2022-07-22       Impact factor: 10.460

Review 5.  Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity.

Authors:  Lucy Darakjian; Malavika Deodhar; Jacques Turgeon; Veronique Michaud
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.